Genetic Engineering & Biotechnology News

AUG 2014

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D; community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: http://gen.epubxp.com/i/350894

Contents of this Issue

Navigation

Page 14 of 45

For Research Use Only. Not for use in diagnostic procedures. © 2014 Thermo Fisher Scientifc Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientifc and its subsidiaries unless otherwise specifed. CO116925 0714 Discover the versatile reagent with the power to transfect your most diffcult cells. Find out more at lifetechnologies.com/3000 Join the conversation at #DiffCells 10-fold higher transfection effciency in diffcult cells We were very happy and surprised to see Lipofectamine ® 3000 reagent provide a more than 10-fold difference in transfection effciency in our diffcult-to-transfect cell line. There was even a reduction in cell death. Awesome results! —Rui Eduardo Castro, PhD, University of Lisbon

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - AUG 2014